Bokus

W. Hiddemann – författare

Visar alla böcker från författaren W. Hiddemann. Handla med fri frakt och snabb leverans.

11 produkter

  1. B. Wormann, B. Wörmann, W. Hiddemann, T. Büchner - Prognostic Factors and Treatment Strategies, Inbunden. Tillgänglighet: Lägg i varukorg

    Prognostic Factors and Treatment Strategies

    Av B. Wormann, B. Wörmann m. fl.

    Inbunden, 2001

    903 kr

    Lägg i varukorg

    Since 1987 Acute Leukemias (AL) has regularly reported on the state of the art in the rapidly growing, successful and exciting field of biology and management of these diseases. In this volume large multicenter clinical trials again form the solid basis for the investigation of leukemic cell …

  2. W. Hiddemann, R. Mertelsmann - New Findings on Aclarubicin in the Treatment of Acute Myeloid Leukemia, Häftad. Tillgänglighet: Lägg i varukorg

    New Findings on Aclarubicin in the Treatment of Acute Myeloid Leukemia

    Av W. Hiddemann, R. Mertelsmann

    Häftad, 1990

    1128 kr

    Lägg i varukorg

    Since the introduction of new anthracycline derivatives and anthrachi­ none analogues a few years ago, aclacinomycin A (Aclarubicin) has become an established agent for the treatment of hematologic malig­ nancies. A special symposium was therefore held during the congress of the German Society of …

  3. W. Hiddemann, T. Büchner, W. Plunkett, M. Keating, B. Wörmann, M. Andreeff - Acute Leukemias, Häftad. Tillgänglighet: Lägg i varukorg

    Acute Leukemias

    Pharmacokinetics and Management of Relapsed and Refractory Disease

    Av W. Hiddemann, T. Büchner m. fl.

    Häftad, 1992

    569 kr

    Lägg i varukorg

    Following the major breakthroughs in the and frequent and thorough exchange of treatment of acute leukemias in the seven- information. Hence, it was felt that a spe- ties by the introduction of intensive combi- cial series of symposia should be devoted to nation regimens, therapeutic progress has …

  4. W. Hiddemann - Medizin im Brennpunkt, Häftad. Tillgänglighet: Lägg i varukorg

    Medizin im Brennpunkt

    Aktuelle Fragen der klinischen Medizin

    Av W. Hiddemann

    Häftad, 2000

    583 kr

    Lägg i varukorg

    Die Rubrik "Leser fragen, Experten antworten" in den Facharzt-Zeitschriften des Springer-Verlages stößt seit ihrer Einführung auf großes Interesse. Das vorliegende Buch stellt eine Zusammenfassung dieser Rubrik aus den unterschiedlichen Facharzt-Zeitschriften dar und spiegelt damit die …

  5. U. Creutzig, J. Ritter, G. Schellong, B. Wormann, W. Hiddemann, T. Buchner - Acute Leukemias VIII, E-bok. Tillgänglighet: Lägg i varukorg

    Acute Leukemias VIII

    Prognostic Factors and Treatment Strategies

    Av U. Creutzig, J. Ritter m. fl.

    E-bok, 2012

    739 kr

    Lägg i varukorg

    Since 1987 Acute Leukemias (AL) has regularly reported on the state of the art in the rapidly growing, successful and exciting field of biology and management of these diseases. In this volume large multicenter clinical trials again form the solid basis for the investigation of leukemic cell …

  6. W. Hiddemann - Medizin im Brennpunkt, E-bok. Tillgänglighet: Lägg i varukorg

    Medizin im Brennpunkt

    Aktuelle Fragen der klinischen Medizin

    Av W. Hiddemann

    E-bok, 2013

    604 kr

    Lägg i varukorg

    Die Rubrik "Leser fragen, Experten antworten" in den Facharzt-Zeitschriften des Springer-Verlages stößt seit ihrer Einführung auf großes Interesse. Das vorliegende Buch stellt eine Zusammenfassung dieser Rubrik aus den unterschiedlichen Facharzt-Zeitschriften dar und spiegelt damit die …

  7. T. Büchner, W. Hiddemann, B. Wörmann, G. Schellong, J. Ritter, U. Creutzig - Acute Leukemias VIII, Häftad. Tillgänglighet: Lägg i varukorg

    Acute Leukemias VIII

    Prognostic Factors and Treatment Strategies

    Av T. Büchner, W. Hiddemann m. fl.

    Häftad, 2012

    569 kr

    Lägg i varukorg

    Since 1987 Acute Leukemias (AL) has regularly reported on the state of the art in the rapidly growing, successful and exciting field of biology and management of these diseases. In this volume large multicenter clinical trials again form the solid basis for the investigation of leukemic cell …

  8. R. Mertelsmann, W. Hiddemann - New Findings on Aclarubicin in the Treatment of Acute Myeloid Leukemia, E-bok. Tillgänglighet: Lägg i varukorg

    New Findings on Aclarubicin in the Treatment of Acute Myeloid Leukemia

    Av R. Mertelsmann, W. Hiddemann

    E-bok, 2012

    1502 kr

    Lägg i varukorg

    Since the introduction of new anthracycline derivatives and anthrachi­ none analogues a few years ago, aclacinomycin A (Aclarubicin) has become an established agent for the treatment of hematologic malig­ nancies. A special symposium was therefore held during the congress of the German Society of …

  9. M. Andreeff, B. Wormann, M. Keating, W. Plunkett, T. Buchner, W. Hiddemann - Acute Leukemias, E-bok. Tillgänglighet: Lägg i varukorg

    Acute Leukemias

    Pharmacokinetics and Management of Relapsed and Refractory Disease

    Av M. Andreeff, B. Wormann m. fl.

    E-bok, 2012

    755 kr

    Lägg i varukorg

  10. J. Ritter, G. Schellong, B. Wormann, W. Hiddemann, T. Buchner - Acute Leukemias IV, E-bok. Tillgänglighet: Lägg i varukorg

    Acute Leukemias IV

    Prognostic Factors and Treatment Strategies

    Av J. Ritter, G. Schellong m. fl.

    E-bok, 2012

    1470 kr

    Lägg i varukorg

    The rates of acute leukemia cure have gradually improved over the last decade. Clinical study results reflect the impact of chemotherapy intensity and duration, the role of prolonged maintenance, intensified consolidation or very early intensification. Further progress has also been achieved in …

  11. T. Büchner, W. Hiddemann, B. Wörmann, G. Schellong, J. Ritter - Acute Leukemias IV, Häftad. Tillgänglighet: Lägg i varukorg

    Acute Leukemias IV

    Prognostic Factors and Treatment Strategies

    Av T. Büchner, W. Hiddemann m. fl.

    Häftad, 2011

    1128 kr

    Lägg i varukorg

    The rates of acute leukemia cure have gradually improved over the last decade. Clinical study results reflect the impact of chemotherapy intensity and duration, the role of prolonged maintenance, intensified consolidation or very early intensification. Further progress has also been achieved in …